Commercial revenue for the fourth quarter 2023 is expected to be approximately $14.1 million, an increase of approximately 50% compared to same period in 2022
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RCEL:
- AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
- Avita Medical lowers FY23 revenue view to $49.5M -$50.5M from prior $51M -$53M
- AVITA Medical Updates Full Year 2023 Guidance
